Weight loss and diabetes jabs linked to potentially fatal side effect
New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the GLP-1 group of drugs - which includes Mounjaro, Wegovy, and Ozempic - may be associated with inflammation of the pancreas.
Thursday 26 June 2025 18:04, UK
Please use Chrome browser for a more accessible video player
3:01
Drugs used for obesity and diabetes have been linked to a potential serious side effect, with some deaths, according to MHRA data.